IVF Success Rates for Advanced Maternal Age in Thailand: Impact of Age on Live Birth Rate and Clinical Decision-Making

AI Citation Summary

Main Content Begins

Clinical Decision-Making Logic: Age is the Starting Point for All Issues

In the clinical evaluation of reproductive medicine, age is the first parameter entered into the decision tree. For older women considering IVF in Thailand, the first question the doctor must answer is not "What is the success rate?" but "Does your biological age match your ovarian age?" This judgment determines the direction of all subsequent treatment strategies—the choice of ovarian stimulation protocol, embryo culture strategy, whether to perform PGT-A, and the timing of embryo transfer.

The essence of IVF success rates for advanced maternal age is the inverse relationship between egg quality and age. Understanding the biological basis of this relationship is essential for forming a sober and realistic expectation of the "success rate."

Live Birth Rates by Age Group: Stratified Data Based on Clinical Statistics

Clinical statistics from Thai fertility centers are consistent with international trends: age is the strongest independent predictor of live birth rate. The following are approximate ranges for live birth rates per transfer cycle (based on euploid embryo transfer data; success rates for cycles without PGT-A will be lower):

Biological Mechanisms of Age Impact on Success Rate

There are two core reasons for the decline in fertility due to advanced age: mitochondrial dysfunction in oocytes and an increased rate of chromosomal aneuploidy. Together, these factors lead to a comprehensive decline in fertilization rate, embryo developmental potential, implantation capacity, and pregnancy maintenance ability in older women.

• Accumulation of mitochondrial DNA mutations: During egg aging, the efficiency of mitochondrial energy metabolism decreases, affecting every step of fertilization and embryo development.
• Sharp rise in aneuploidy rate with age: Approximately 30% at age 35, 60% at age 40, and over 80% after 43. This is the most direct cause of the decline in IVF success rates for older women.
• Decline in granulosa cell function: Changes in the follicular microenvironment affect the developmental support for oocytes.
• Decreased ovarian reserve: Reduced number of follicles, diminished response to ovarian stimulation drugs, and fewer eggs retrieved.

It is important to note that the decline in egg quality is a biological process independent of ovarian reserve. A 42-year-old woman with normal AMH may have a reasonable number of follicles, but the euploidy rate of her eggs is still very low. This is a biological limitation of age itself that cannot be reversed by any form of "optimization."

Physician's Perspective: Framework for Individualized Prognosis Assessment

When evaluating older patients, reproductive specialists do not look only at age but integrate the following factors to build an individualized prognostic profile:

• Chronological age: The most basic and important indicator, directly linked to the euploidy rate.
• Ovarian reserve indicators: AMH, AFC (antral follicle count), basal FSH. Combined assessment of these three can relatively accurately predict ovarian response.
• Previous fertility history: History of natural conception, miscarriage, or embryo implantation provides reference value for evaluating uterine factors and endocrine status.
• Previous IVF history: Whether euploid embryos have been obtained before, as well as embryo developmental grade and transfer outcomes.
• Male factors: Sperm concentration, motility, morphology, and DNA fragmentation index (DFI). Elevated DFI in older men increases the risk of embryo aneuploidy.
• Uterine factors: Endometrial receptivity, uterine cavity pathology (polyps, adhesions, fibroids), etc., need to be ruled out through ultrasound, hysteroscopy, and other examinations.

For older women undergoing IVF in Thailand, doctors also pay special attention to the fertility center's embryo culture system and experience with PGT-A technology. Embryos from older patients often develop more slowly and have higher fragmentation rates, requiring experienced embryologists and a stable culture system to maximize the utilization efficiency of each egg.

Core Strategy Differences by Age Group

35–38 years

• Ovarian reserve is generally adequate, but attention should still be paid to whether AMH levels are lower than peers.
• Number of eggs retrieved per cycle is typically 8–15, with a euploidy rate of about 40–50%.
• Recommendation: Standard ovarian stimulation protocol; PGT-A is optional. If there is a history of miscarriage or recurrent implantation failure, the benefit of PGT-A is more pronounced.

39–42 years

• Ovarian reserve is significantly reduced, with the number of eggs retrieved decreasing to 4–8.
• Euploidy rate is about 20–35%, meaning approximately 1 in every 2–3 blastocysts is euploid.
• Recommendation: Individualized ovarian stimulation protocol (e.g., mild stimulation or antagonist protocol); PGT-A is strongly recommended. Be mentally prepared for multiple cycles to accumulate embryos.

Over 43 years

• Ovarian reserve is very low, with the number of eggs retrieved typically <4; some cycles may be cancelled due to no follicular growth.
• Euploidy rate <15%; sometimes 3–4 cycles are needed to obtain a single euploid embryo.
• Recommendation: Mild stimulation or natural cycle protocol; PGT-A is mandatory. An embryo accumulation strategy (collecting 2–3 embryos for a single transfer) should be adopted. Patients must be fully informed of the very low live birth expectation.

Easily Overlooked Details

1. AMH Reflects Follicle Quantity, Not Quality

A 42-year-old woman with an AMH of 3.0 ng/mL has a reasonable number of follicles, but egg quality is still constrained by age; the euploidy rate will not improve because of high AMH. Older patients with high AMH may simply retrieve more eggs, but the risk of aneuploidy per egg is the same as that of their peers.

2. Cycle-to-Cycle Variability of FSH

Basal FSH is measured on days 2–4 of the menstrual cycle, but there can be 20–30% fluctuation between different cycles. A single elevated FSH level (e.g., 12 IU/L) does not directly indicate ovarian failure; it must be interpreted in conjunction with AMH and AFC. FSH >15 IU/L for two consecutive cycles with AMH <0.5 ng/mL suggests severely diminished ovarian reserve.

3. Male Age Also Affects Embryo Quality

In IVF for advanced maternal age in Thailand, the male partner's age is often underestimated. Sperm DNA fragmentation index (DFI) increases in men over 40, raising the risk of embryo aneuploidy and miscarriage after fertilization. It is recommended that older couples also undergo semen analysis and DFI testing.

4. Limitations of PGT-A

PGT-A can screen for euploid embryos but cannot increase the number of euploid embryos. For women over 43, it is possible that all embryos are aneuploid, resulting in no embryos available for transfer. This is the harshest biological reality of IVF at an advanced age, which technology cannot solve.

Common Pitfalls to Avoid

Pitfall 1: Blindly Believing "Ovarian Optimization" Can Reverse Age

Most "ovarian rejuvenation" or "mitochondrial activation" programs on the market lack high-quality evidence. Supplements like Coenzyme Q10, DHEA, and melatonin may offer marginal benefits for some individuals (mainly improving follicle uniformity or lowering FSH), but no method can reverse the age-related increase in chromosomal aneuploidy in eggs. A lack of awareness of this can lead patients to waste time and money on ineffective "optimization," delaying the optimal treatment window.

Pitfall 2: Focusing Only on Single-Transfer Success Rate, Ignoring Cumulative Cycle Success Rate

A low success rate per single transfer does not mean there is no hope. For a 42-year-old patient, the live birth rate per egg retrieval cycle may be only 10–15%, but if 3–4 cycles are performed, the cumulative live birth rate can rise to 30–40%. Doctors need to help patients establish a "cumulative cycle" expectation rather than giving up after a single failure.

Pitfall 3: Blindly Pursuing High Egg Numbers with Excessive Stimulation

When older patients have a poor ovarian response, increasing the dose of ovarian stimulation drugs does not guarantee more high-quality eggs. Excessive stimulation may increase the number of eggs retrieved but decrease egg quality (higher proportion of immature eggs), while also raising the risk of OHSS and cycle cancellation. An individualized mild stimulation protocol is often more effective than high-intensity stimulation.

Pitfall 4: Neglecting to Investigate Uterine Cavity Pathology

The incidence of endometrial polyps, submucosal fibroids, intrauterine adhesions, and chronic endometritis increases in older patients. If these conditions are not treated before transfer, even euploid embryos may fail to implant. Some fertility centers in Thailand routinely perform hysteroscopy for patients with recurrent implantation failure.

Interpretation of Key Diagnostic Indicators

Management of Special Situations

Very Low Ovarian Reserve (AMH < 0.5 ng/mL)

• Recommend mild stimulation (e.g., clomiphene + low-dose gonadotropins) or natural cycle protocols to reduce cycle cancellation rates.
• Consider an embryo accumulation strategy: collect 2–3 embryos for a single transfer to improve the pregnancy probability per transfer.
• Some fertility centers in Thailand have dedicated minimal stimulation pathways for very low reserve, but it is necessary to confirm in advance whether the laboratory can handle embryo culture from single-follicle cycles.

History of Multiple Previous Failures (≥2 euploid embryo transfers without implantation)

• Systematic investigation is needed: embryo factors (PGT-A missed detection, mosaicism), uterine factors (ERA for endometrial receptivity, chronic endometritis), endocrine factors (thyroid, prolactin, vitamin D), immune factors (antiphospholipid antibodies, NK cells, etc.).
• ERA testing is recommended to rule out displaced endometrial window.
• Some centers in Thailand have dedicated diagnostic and treatment pathways for recurrent implantation failure, including endometrial injury, PRP infusion, and other adjunctive techniques, but their efficacy requires further evidence.

Advanced Age with Underlying Medical Conditions

• Hypertension, diabetes: Must be well controlled before IVF; risk of pregnancy complications is significantly increased, requiring co-management with an internist.
• Thyroid dysfunction: TSH should be controlled below 2.5 mIU/L before starting a cycle.
• Vitamin D levels: Test and supplement to above 30 ng/mL, as it is associated with embryo implantation rates and pregnancy outcomes.
• Weight management: BMI > 30, recommend losing 5–10% of body weight before starting a cycle to improve ovarian response and pregnancy outcomes.

Clinician's Observation: The Most Underestimated Psychological Cost of IVF at Advanced Age

In clinical practice, a frequently overlooked reality is that patients undergoing IVF at an advanced age face significantly higher psychological stress than younger populations. Each time the number of eggs retrieved is low, each time they are told an embryo is aneuploid, each time they wait for a pregnancy test after transfer—these moments carry not only the hope of fertility for older patients but also anxiety about the passage of time. Both doctors and patients need to recognize that IVF at an advanced age is a process requiring a "cycle mindset" rather than a "one-time success mindset." Setting reasonable expectations, building a support system, and seeking psychological intervention when necessary are indispensable parts of the treatment plan.

End: Risk Reminder